Specialty Chemicals company Atul announced Q1FY27 results Consolidated Financial Highlights: Total Revenue from operations for Q1FY27 stood at Rs 1,847.95 crore, representing a growth of 10.65% QoQ compared to Rs 1,670.07 crore in Q4FY26 and an increase of 25.03% YoY against Rs 1,478.00 crore in Q1FY26. Total Income for the quarter was reported at Rs 1,881.26 crore, up by 6.91% QoQ from Rs 1,759.64 crore in Q4FY26 and rising 25.06% YoY from Rs 1,504.24 crore in Q1FY26. Profit before tax for Q1FY27 was Rs 346.83 crore, showing a growth of 20.13% QoQ from Rs 288.71 crore in Q4FY26 and a significant jump of 95.91% YoY compared to Rs 177.03 crore in Q1FY26. Net Profit for the quarter reached Rs 253.93 crore, marking an increase of 20.28% QoQ from Rs 211.12 crore in Q4FY26 and a 91.85% YoY increase from Rs 132.36 crore in Q1FY26. Total Comprehensive Income for the period was Rs 375.41 crore in Q1FY27, compared to Rs 160.78 crore in Q4FY26 and Rs 308.90 crore in Q1FY26. Basic Earnings Per Share (EPS) for Q1FY27 stood at Rs 83.32, compared to Rs 71.38 in Q4FY26 and Rs 43.40 in Q1FY26. Standalone Financial Highlights: Revenue from operations for Q1FY27 was recorded at Rs 1,588.60 crore, reflecting a 6.05% QoQ growth from Rs 1,497.93 crore in Q4FY26 and a 21.77% YoY increase from Rs 1,304.56 crore in Q1FY26. Total Income for the quarter stood at Rs 1,614.91 crore, an increase of 2.67% QoQ from Rs 1,572.89 crore in Q4FY26 and a growth of 21.10% YoY compared to Rs 1,333.53 crore in Q1FY26. Profit before tax reached Rs 269.85 crore in Q1FY27, up 8.49% QoQ from Rs 248.74 crore in Q4FY26 and more than doubling YoY with a 100.62% increase from Rs 134.51 crore in Q1FY26. Net Profit for the period was Rs 201.03 crore, showing a slight decrease of 1.38% QoQ from Rs 203.84 crore in Q4FY26, but a substantial growth of 105.68% YoY against Rs 97.74 crore in Q1FY26. Total Comprehensive Income for Q1FY27 was Rs 321.37 crore, compared to Rs 146.97 crore in Q4FY26 and Rs 266.33 crore in Q1FY26. Basic Earnings Per Share (EPS) for the standalone entity was Rs 68.28 for Q1FY27, against Rs 69.24 in Q4FY26 and Rs 33.20 in Q1FY26. Business Highlights: Segment-wise Performance: Performance and Other Chemicals: The segment's revenue for Q1FY27 was Rs 1,427.44 crore, showing a growth of 15.00% QoQ from Rs 1,241.30 crore in Q4FY26 and a 33.79% YoY increase from Rs 1,066.93 crore in Q1FY26. Life Science Chemicals: Revenue for this segment stood at Rs 469.23 crore in Q1FY27, compared to Rs 461.74 crore in Q4FY26 and Rs 449.20 crore in Q1FY26. Others: Revenue from other segments was Rs 25.98 crore in Q1FY27, up from Rs 19.09 crore in Q4FY26. Director Appointment: The Board of Directors appointed Mr Vinayak Deshpande as an Additional Director and Independent Director of the Company effective August 01, 2026, for a period of five consecutive years, subject to shareholder approval. One-time Gains Note: The company noted that employee benefit expenses for Q4FY26 had included a reversal of excess provision (gain) of Rs 24.38 crore (Standalone) and Rs 25.41 crore (Consolidated) due to the reassessment of gratuity and leave encashment following the implementation of the new labour code. Result PDF